This study has found significant relationships between the blood concentration of two endocannabinoid neurotransmitters with clinical variables and body mass index (BMI) in a group of patients with extreme clinical weight conditions.
The results show that a protein, NADPH oxidase NOX4, which had been described as a mediator of TGF-beta-induced cell death, also participates in the pro-tumorogenic response to this factor, specifically mediating its pro-migratory and invasive effects.
The analysis of brain involvement at an individual level has shown that there is a great heterogeneity in the affected regions in individuals with the same clinical diagnosis. In contrast, alterations in neural circuits and networks involving different regions are common among various mental disorders and could therefore become useful as diagnostic markers.
First assessment of individual brain heterogeneity in mental disorders Read More »
According to the study carried out by the IDIBELL research group on cardiovascular diseases (BIOHEART), this program not only could reduce hospital admissions and deaths of patients 30 days after discharge – as it was already proven – but also at 90 and 180 days.
The Bellvitge Hospital, Primary Care and IDIBELL have analyzed the cases of more than 77,500 heart failure patients in Catalonia between 2015 and 2019.
A research work led by neuroradiologists and neurologists from IDIBELL, the Bellvitge University Hospital, and the Institute of Diagnostic Imaging identified a new magnetic resonance biomarker. This biomarker would make it possible to accurately detect the focus of chronic brain inflammation, associated with the progressive form of multiple sclerosis.
Imaging biomarker may help to better understand and treat progressive multiple sclerosis Read More »
In a phase 2 clinical trial, researchers have observed that this combination allows to carry out global treatment from the beginning, manages to keep metastases stable for 7
Led by the Centre for Research and Technology Hellas (CERTH), the project includes 27 complementary partners from different research domains. This initiative integrates cutting-edge research methodologies powered by artificial intelligence to deliver personalized, evidence-based approaches for preventing this type of cancer.
The results of five studies have been reviewed, two of them randomized clinical trials, with a total of 691 episodes of febrile neutropenia. The effects of the use of beta-lactam antibiotics in intermittent infusions have been compared with prolonged infusions.
Dr. Josep Manuel Menchon, group leader at IDIBELL and head of the Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire to address and reduce the risks of harmful Internet use among adolescents.
New research will look for risk indicators of harmful internet use among adolescents Read More »
